Lilly’s 2026 dealmaking spreads the wealth among biotech venture investors

At least 50 different venture investors have benefited from Eli Lilly’s dealmaking this year, sending early investment dollars back into the startup ecosystem. On Monday, Lilly announced its 13th acquisition of the year, up to ...